As such, our findings provide further support for the therapeutic rationale to intervene in disease progression by targeting viral infection, either with vaccination or with antiviral therapies [27]: a multivalent enterovirus vaccine has been recently produced [40] and, as noted above, therapy with antiviral agents was associated with preservation of insulin secretion in newly diagnosed individuals [29]. This evidence concerns the gene INS and viral infectious disease.